Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of Pglycoprotein inhibitor in PLGAbased nanovectors

Author：            

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.2, 2014-01, pp. : 387-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin

By O'Loughlin C.   Heenan M.   Coyle S.   Clynes M.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1149-1160

Elsevier

Access to resources Recommend Favorite

Modulation of P-glycoprotein Mediated Drug Accumulation in Multidrug Resistant CCRF VCR-1000 Cells by Chemosensitisers

By Boer R.   Gekeler V.   Ulrich W.-R.   Zimmermann P.   Ise W.   Schodl A.   Haas S.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 857-861

Elsevier

Access to resources Recommend Favorite

Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line

By      

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2065-2072

Spandidos Publications

Access to resources Recommend Favorite

Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes

By                

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1589-1600

Spandidos Publications

Access to resources Recommend Favorite